Organization: Hanson Wade
Venue: Maritim Hotel Berlin
|Event Date/Time: Feb 18, 2014||End Date/Time: Feb 20, 2014|
Following the previous success of our World CTC Summit meetings, Circulate will once again bring together leaders across Europe, to evaluate the latest technologies fuelling this field and explore the most recent clinical studies in circulating cancer biomarker validation.
Witness first hand case studies demonstrating the impact CTCs, cfDNA, exosomesand miRNA can have on real time monitoring & personalised therapy in patient care. Understand the invaluable information that can be attained from furthercharacterisation of CTCs and how its application could revolutionise the way we currently treat patients.
With industry participation from pharma, biotechs and leading research institutes,Circulate will compliment your existing understanding with eye-opening insights into successful clinical applications. Understand the steps you need to take to advance your biomarker assay into sophisticated, cost-effective companion diagnostics.
Evaluate the expanding market of new technologies in CTC capture, enumeration & characterisation to choose the right platform for you
Learn how the industry is using characterisation of circulating cancer biomarkers to improve clinical decision making and achieve personalised treatment for patients
Understand how exosomes and miRNAs can be effectively used as biomarkers for early detection and management of cancer
Explore the field of companion diagnostics to understand how to advance your circulating cancer biomarkers into cost-effective clinical diagnostics